Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Related Articles by Review for PubMed (Select 16879014)

1.

Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis.

Ahmed A, Chang CC.

Arch Pathol Lab Med. 2006 Aug;130(8):1133-43. Review.

PMID:
16879014
2.

Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).

Michiels JJ, Bernema Z, Van Bockstaele D, De Raeve H, Schroyens W.

Pathol Biol (Paris). 2007 Mar;55(2):92-104. Epub 2006 Aug 21. Review.

PMID:
16919893
3.

The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.

Michiels JJ, De Raeve H, Berneman Z, Van Bockstaele D, Hebeda K, Lam K, Schroyens W.

Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):307-40. Review.

PMID:
16810609
4.

Polycythemia vera: new clinicopathologic perspectives.

Cao M, Olsen RJ, Zu Y.

Arch Pathol Lab Med. 2006 Aug;130(8):1126-32. Review.

PMID:
16879013
6.

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.

Michiels JJ, De Raeve H, Hebeda K, Lam KH, Berneman Z, Schroyens W, Schwarz J.

Leuk Res. 2007 Aug;31(8):1031-8. Epub 2007 Mar 23. Review.

PMID:
17367853
7.

Polycythemia vera: scientific advances and current practice.

Tefferi A, Spivak JL.

Semin Hematol. 2005 Oct;42(4):206-20. Review.

PMID:
16210034
9.

Hematopathologic findings in chronic idiopathic myelofibrosis.

Thiele J, Kvasnicka HM.

Semin Oncol. 2005 Aug;32(4):380-94. Review.

PMID:
16202684
10.

Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.

Michiels JJ, Kutti J, Stark P, Bazzan M, Gugliotta L, Marchioli R, Griesshammer M, van Genderen PJ, Brière J, Kiladjian JJ, Barbui T, Finazzi G, Berlin NI, Pearson TC, Green AC, Fruchtmann SM, Silver RT, Hansmann E, Wehmeier A, Lengfelder E, Landolfi R, Kvasnicka HM, Hasselbalch H, Cervantes F, Thiele J, et al.

Neth J Med. 1999 Feb;54(2):46-62. Review.

PMID:
10079679
11.

Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.

Thiele J, Kvasnicka HM, Vardiman J.

Best Pract Res Clin Haematol. 2006;19(3):413-37. Review.

PMID:
16781481
12.

Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.

Tefferi A.

Am J Hematol. 2013 Feb;88(2):141-50. doi: 10.1002/ajh.23384. Review. Erratum in: Am J Hematol. 2013 May;88(5):437-45.

PMID:
23349007
13.

[New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation].

Larsen TS, Pallisgaard N, Christensen JH, Gram-Hansen P, Kerndrup GB, Møller MB, Hasselbalch HC.

Ugeskr Laeger. 2006 Sep 25;168(39):3299-303. Review. Danish.

PMID:
17032592
14.

[New insight into pathogenesis of idiopathic myelofibrosis--review].

Xu ZQ, Sun XM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Dec;15(6):1330-4. Review. Chinese.

PMID:
18088495
15.

Idiopathic myelofibrosis.

Barosi G, Hoffman R.

Semin Hematol. 2005 Oct;42(4):248-58. Review.

PMID:
16210038
17.
18.

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).

Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, Verstovsek S, Dupriez B, Silver RT, Odenike O, Cortes J, Wadleigh M, Solberg LA Jr, Camoriano JK, Gisslinger H, Noel P, Thiele J, Vardiman JW, Hoffman R, Cross NC, Gilliland DG, Kantarjian H; IWG for Myelofibrosis Research and Treatment (IWG-MRT).

Blood. 2006 Sep 1;108(5):1497-503. Epub 2006 May 4. Review.

19.

New insights into the pathogenesis of JAK2 V617F-positive myeloproliferative disorders and consequences for the management of patients.

Villeval JL, James C, Pisani DF, Casadevall N, Vainchenker W.

Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):341-51. Review.

PMID:
16810610
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk